Lusaris Therapeutics
About:
Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.
Website: https://lusaristx.com
Twitter/X: LusarisTx
Top Investors: RA Capital Management, Deep Track Capital, Venrock Healthcare Capital Partners, Boxer Capital
Description:
Lusaris is a drug development company that offers neuropsychiatric and neurological therapeutics. The company has a team of experienced drug developers and company builders with extensive neuroscience experience. Lusaris was founded in 2021 and is headquartered in Boston, Massachusetts.
$60M
Boston, Massachusetts, United States
2021-11-01
Edward Monaghan
1-10
2022-11-02
Private
© 2025 bioDAO.ai